US2015259535A1PendingUtilityA1

Fluorescent dyes

Assignee: ANASPEC INCPriority: Jul 2, 2004Filed: Dec 29, 2014Published: Sep 17, 2015
Est. expiryJul 2, 2024(expired)· nominal 20-yr term from priority
C07D 487/14G01N 33/533C07D 498/22C09B 23/0066C09B 23/02C09B 23/06G01N 33/52C07D 487/22Y10T436/143333
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and 3′-position, their bioconjugates and their uses are described. 1,3′-crosslinked carbocyanines are superior to those of conjugates of spectrally similar 1,1′-crosslinked or non-crosslinked dyes. The invention includes derivative compounds having one or more benzo nitrogens.

Claims

exact text as granted — not AI-modified
1 . A compound of the following structure: 
       
         
           
           
               
               
           
         
         and its biological salts, 
         wherein C is a non-conjugated chain of 10-50 linear atoms selected from a group consisting of carbon, oxygen and nitrogen and wherein C is substituted with substituents selected from a group consisting of hydrogen, an alkyl having 1 to 20 carbons, a hydroxyl, a carbonyl, and RGM; 
         R 1 -R 11  and R 13 -R 14  are selected from a group consisting of hydrogen, an alkyl having 1 to 20 carbons, an alkoxy having 1-20 carbons, a trifluoromethyl, a halogen, a methylthio, a sulfonyl, a carbonyl, a hydroxyl, an amino, a thiol or a RGM; 
         X is O or S; 
         n is 0 to 3; 
         wherein RGM is an activated ester, acyl halide, aldehyde, anhydride, carbodiimide, haloacetamide, isocyanate or maleimide. 
       
     
     
         2 . The compound according to  claim 1 , wherein C is a non-conjugated chain of 10 to 50 linear atoms selected from a group consisting of carbon and nitrogen. 
     
     
         3 . The compound according to  claim 1 , wherein C is substituted with substituents selected from a group consisting of hydrogen, a carbonyl and RGM. 
     
     
         4 . The compound according to  claim 1 , wherein R 1 -R 11  and R 13 -R 14  are selected from a group consisting of hydrogen, a halogen, a sulfonyl, a carbonyl or a RGM. 
     
     
         5 . The compound according to  claim 2 , wherein C is substituted with substituents selected from a group consisting of hydrogen, a carbonyl and RGM. 
     
     
         6 . The compound according to  claim 6 , wherein R 1 -R 11  and R 13 -R 14  are selected from a group consisting of hydrogen, a halogen, a carbonyl or a RGM. 
     
     
         7 . A compound of the following structure: 
       
         
           
           
               
               
           
         
         and its biological salts, 
         wherein C is a non-conjugated chain of 10-50 linear atoms selected from a group consisting of carbon, oxygen and nitrogen and wherein C is substituted with substituents selected from a group consisting of hydrogen, an alkyl having 1 to 20 carbons, a hydroxyl, a carbonyl, and RGM; 
         R 1 -R 11  and R 13 -R 16  are selected from a group consisting of hydrogen, an alkyl having 1 to 20 carbons, an alkoxy having 1-20 carbons, a trifluoromethyl, a halogen, a methylthio, a sulfonyl, a carbonyl, a hydroxyl, an amino, a thiol or a RGM; 
         n is 0 to 3; 
         wherein RGM is an activated ester, acyl halide, aldehyde, anhydride, carbodiimide, haloacetamide, isocyanate or maleimide.

Join the waitlist — get patent alerts

Track US2015259535A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.